Canagliflozin heMihydrate
-
Canagliflozin heMihydrate
structure -
-
CAS No:
928672-86-0
-
Formula:
2(C24H25FO5S).H2O
-
Chemical Name:
Canagliflozin heMihydrate
-
Synonyms:
Cagliflozin heMihydrate;Canagliflozin hydrate (2:1);Canagliflozin heMihydrate;D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, hydrate (2:1);Canagliflozin heMihydrates;(2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol Hemihydrate;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol hydrate (2:1);Cageline
- Categories:
-
CAS No:
Description
Canagliflozin 0.5 H2O(JNJ 28431754; TA 7284) is a highly potent and selective SGLT2 inhibitor for hSGLT2 with IC50 of 2.2 nM, exhibits 413-fold selectivity over hSGLT1.IC50 value: 2.2 nMTarget: SGLT2Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an experimental drug being developed by Johnson & Johnson for the treatment of type 2 diabetes.Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an inhibitor of subtype 2 sodium-glucose transport
Canagliflozin, an orally active and selective sodium–glucose cotransporter 2 (SGLT2) inhibitor, was co-developed by Mitsubishi Tanabe Pharma and Johnson & Johnson (J&J) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. The drug was approved in March by the U.S. FDA and launched in April 2013 in the U.S. SGLT2 is involved in the glucose re-absorption pathway in the kidney, and its inhibition increases urinary glucose excretion, and reduces plasma glucose and HbA1c levels. In addition, canagliflozin is safe in combination with other commonly used antidiabetic agents and has a significant effect on body weight reduction. A recently published process patent from ScinoPharm Taiwan describes the synthesis of canagliflozin.
ChEBI: Canagliflozin hydrate is a hydrate that is the hemihydrate form of canagliflozin. Used for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. It has a role as a hypoglycemic agent and a sodium-glucose transport protein subtype 2 inhibitor. It contains a canagliflozin.
Characteristics
118
3.44
94-96°C
642.9±55.0
almost insoluble
1.07X10-18 mm Hg at 25 °C (est)
13.34None
Hygroscopic, Refrigerator, under inert atmosphere
Canagliflozin heMihydrate Use and Manufacturing
Canagliflozin Hemihydrate is a derivative of Canagliflozin (C175190), which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.
Recommended Suppliers of Canagliflozin heMihydrate
-
![China]()
CN
7 YRS
Business licensed Certified factoryManufactory Supplier of prostaglandinsInquiryUnit Price: $2222-2322 /KG FOBCAS No.: 928672-86-0Grade: Pharmaceutical GradeContent: 98% -
![China]()
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
![China]()
CN
4 YRS
Business licensedTrader Supplier of Upadacitinib Hemihydrate,(S)-(+)-1-Boc-3-hydroxypyrrolidine -
![China]()
CN
2 YRS
Business licensedTrader Supplier of peptide,Weight loss peptideInquiryCAS No.: 928672-86-0Grade: Pharmaceutical GradeContent: 99% -
![Hongkong, China]()
HK
2 YRS
Business licensedTrader Supplier of PeptidesInquiryCAS No.: 928672-86-0Grade: Industrial GradeContent: 99%
Learn More Other Chemicals
-
4-AMINO-L-PHENYLALANINE HYDROCHLORIDE HEMIHYDRATE
24286-13-3
-
2-AMINO-5-CHLORO-3-METHYLPYRIDINE HEMIHYDRATE
1173019-45-8
-
2-AMINO-1,4-NAPHTHOQUINONE HEMIHYDRATE
20814-38-4
-
Paroxetine hydrochloride hemihydrate Formula
110429-35-1
-
1-DEOXY-1-NITRO-D-IDITOL HEMIHYDRATE Formula
96613-89-7
-
Potassium guaiacolsulfonate hemihydrate Formula
78247-49-1
-
POTASSIUM ACETYLACETONATE HEMIHYDRATE Structure
57402-46-7
-
SulfaMethazine-phenyl-13C6 heMihydrate Structure
1196157-77-3
-
What is Ephedrine hemihydrate
50906-05-3
-
What is 2-Imidazolidone hemihydrate
121325-67-5